IRIS
VISCOLI, CLAUDIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 51.132
Totale 51.132
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 51.132
Totale 51.132
Salva come PNG Salva come JPEG
Città #
Genova 38.338
Rapallo 5.217
Genoa 3.913
Vado Ligure 3.550
Bordighera 114
Totale 51.132
Salva come PNG Salva come JPEG
Nome #
Inflammation markers correlate with common carotid intima-media thickness in patients perinatally infected with human immunodeficiency virus 1. 194
The Ligurian Human Immunodeficiency Virus Clinical Network: A Web Tool to Manage Patients With Human Immunodeficiency Virus in Primary Care and Multicenter Clinical Trials 189
Emergence of a KPC-3-Producing Escherichia coli ST69 as a Cause of Bloodstream Infections in Italy 186
Bench-to-bedside review: therapeutic management of invasive candidiasis in the intensive care unit 175
Is it still worthwhile to perform quarterly CD4+ T lymphocyte cell counts on HIV-1 infected stable patients? 175
Initial serum (1,3)-β-d-glucan as a predictor of mortality in proven candidaemia: findings from a retrospective study in two teaching hospitals in Italy and Brazil 168
Increased CD38 expression on T lymphocytes as a marker of HIV dissemination into the central nervous system 166
A tool for the evaluation of the cost effectiveness of AIDS therapies 164
Trend of eGFR in an Italian cohort of mother-to-child HIV-infected patients exposed to tenofovir for at least 2 years. 164
Randomised, multicentre trial of micafungin vs. an institutional standard regimen for salvage treatment of invasive aspergillosis. 161
Case report: management and HBV sequencing in a patient co-infected with HBV and HIV failing tenofovir. 160
Epidemiological and clinical features of hepatitis delta in HBsAg-positive patients by HIV status. 160
Quality of Life Among Hiv Patients: Results from the Ianua Clinical Trial 158
Kinetics of galactomannan in surgical patients receiving perioperative piperacillin/tazobactam prophylaxis. 157
Prophylaxis and empirical therapy for infection in cancer patients 155
Quantitative ultrasound and bone density in vertically HIV-infected children. 155
Budget impact analysis of sofosbuvir-based regimens for the treatment of HIV/HCV-coinfected patients in northern Italy: A multicenter regional simulation 155
Population pharmacokinetics and probability of target attainment of meropenem in critically ill patients 155
Risk factors for chronic kidney disease among human immunodeficiency virus-infected patients: A European case control study. 154
Evaluation of insulin resistance in a cohort of HIV-infected youth. 150
Pharmacokinetics of Lopinavir Determined with an ELISA Test in Youths with Perinatally Acquired HIV. 149
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy 147
A Standard Interface for Data Reuse in Infectious Diseases 147
Meropenem for treating KPC-producing Klebsiella pneumoniae bloodstream infections: should we get to the PK/PD root of the paradox? 146
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study. 145
Male patient with acute hepatitis E in Genoa, Italy: Figatelli (pork liver sausage) as probable source of the infection 144
Budget Impact Analysis of Sofosbuvir-Based Regimens for The Treatment of Hiv/Hcv Co-Infected Patients In Northern Italy: The Liguria Region Simulation 144
Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt 143
An Italian consensus for invasive candidiasis management (ITALIC). 143
Bacterial infections in hematopoietic stem cell transplantation recipients. 142
Micafungin for the treatment of proven and suspected invasive candidiasis in children and adults: Findings from a multicenter prospective observational study 142
Quality of life in an Italian cohort of people living with HIV in the era of combined antiretroviral therapy (Evidence from I.A.N.U.A. Study-Investigation on Antiretroviral Therapy) 142
Epidemiology, management, and outcome of carbapenem-resistant Klebsiella pneumoniae bloodstream infections in hospitals within the same endemic metropolitan area 142
Bloodstream infections in patients living with HIV in the modern cART era 142
Adherence to international and national recommendations for the prevention of surgical site infections in Italy: results from an observational prospective study in elective surgery. 141
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. 141
Invasive candidiasis in non-hematological patients. 141
Effectiveness of a project to prevent HIV vertical transmission in the Republic of Congo. 141
Effects of hepatitis C virus infection on the pharmacokinetics of ritonavir-boosted atazanavir in HIV-1-infected patients. 141
A systematic review of the antifungal effectiveness and tolerability of amphotericin B formulations 140
Risk factors for infections due to carbapenem-resistant Klebsiella pneumoniae after open heart surgery 139
Antifungal prophylaxis with azole derivatives 138
Pregnancy and neonatal outcomes among a cohort of HIV-infected women in a large Italian teaching hospital: a 30-year retrospective study 138
Implementing TB control in a rural, resource-limited setting: The stop-TB Italia project in Senegal 138
A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. 138
Vancomycin susceptibility of meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia isolates in an Italian hospital. 137
Non-cultural methods for the diagnosis of invasive fungal disease 137
Previous bloodstream infections due to other pathogens as predictors of carbapenem-resistant Klebsiella pneumoniae bacteraemia in colonized patients: results from a retrospective multicentre study 137
Use of maraviroc in clinical practice: a multicenter observational study 136
Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non neutropenic patients: a randomised non-inferiority trial. 135
Pulmonary cryptococcosis with severe eosinophilia in an immunocompetent patient. 133
Bordetella holmesii endocarditis in a patient with systemic lupus erythematous treated with immunosuppressive agents. 133
Galactomannan in piperacillin-tazobactam: how much and to what extent? 132
European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia. 132
Is initial serum (1,3)-β-d-glucan truly associated with mortality in patients with candidaemia? Authors' response 132
Intensified chemotherapy supported by DMSO-free peripheral blood progenitor cells in breast cancer patients. 132
Uso del Platelia Aspergillus Test per il rilevamento di antigeni di galattomannano nel liquor di pazienti con aspergillosi cerebrale. 130
Inpatient admissions of patients living with HIV in two European centres (UK and Italy); comparisons and contrasts 130
Conditions associated with infections of indwelling central venous catheters in cancer patients: a summary 129
Antifungal treatment in patients with cancer 129
Hepatitis B reactivation in HBsAg-negative/HBcAb-positive allogeneic haematopoietic stem cell transplant recipients: risk factors and outcome. 129
Genotypic determination of HIV tropism in a cohort of patients perinatally infected with HIV-1 and exposed to antiretroviral therapy. 129
Liver Enzyme Elevation During Darunavir-Based Antiretroviral Treatment in HIV-1-Infected Patients With or Without Hepatitis C Coinfection: Data from the ICONA Foundation Cohort. 129
Increasing incidence of Clostridium difficile infections: results from a 5-year retrospective study in a large teaching hospital in the Italian region with the oldest population 128
Relationship between innate immunity, soluble markers and metabolic-clinical parameters in HIV+ patients ART treated with HIV-RNA < 50 cp/mL 128
Use of colistin in adult patients: a cross-sectional study 128
Invasive pulmonary aspergillosis in intensive care units: is it a real problem? 127
HIV and accelerated atheroprogression: role of antiretroviral therapy. 127
Risk factors for severe complications of the novel influenza A (H1N1): analysis of patients hospitalized in Italy. 127
La vaccinazione nel paziente con infezione da HIV: attuali raccomandazioni e strategie multidisciplinari per il raggiungimento dei soggetti suscettibili. L’esperienza della Liguria 127
Relevance of CD38 expression on CD8 T cells to evaluate antiretroviral therapy response in HIV-1-infected youths 127
A European Organization for research and treatment of cancer international antimicrobial therapy group study of secondary infections in febrile, neutropenic patients with cancer 126
Different evidence of key amprenavir resistance mutations on the efficacy of darunavir 126
. Italian guidelines for diagnosis, prevention, and treatment of invasive fungal infections in solid organ transplant recipients 126
Candidaemia in internal medicine departments: the burden of a rising problem. 126
Invasive mycoses in children receiving hemopoietic SCT 126
A case of Cunninghamella bertholettiae rhino-cerebral infection in a leukaemic patient and review of recent published studies 126
Disseminated histoplasmosis with mucocutaneous immune reconstitution inflammatory syndrome in an HIV-infected patient 126
Commentary: Human Immunodeficiency Virus and Allergic Bronchopulmonary Aspergillosis 126
Role of serum free light chains in predicting HIV-associated non-Hodgkin lymphoma and Hodgkin's lymphoma and its correlation with antiretroviral therapy. 125
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 125
Mortality after bloodstream infections in allogeneichaematopoietic stem cell transplant (HSCT) recipients 124
The Use of Nucleoside Reverse Transcriptase Inhibitors Sparing Regimens in Treatment-Experienced HIV-1 Infected Patients. 124
Early carbapenem-resistant Klebsiella pneumoniae bacteraemia: should we expand the screening? 124
Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer 123
Predictive Models for Identification of Hospitalized Patients Harboring KPC-Producing Klebsiella pneumoniae. 123
Antigen detection in the diagnosis and management of a patient with probable cerebral aspergillosis treated with voriconazole 123
Guillain-Barré syndrome following chickenpox: A case series 123
Management of KPC-producing Klebsiella pneumoniae infections 123
Regional point prevalence study of healthcare-associated infections and antimicrobial use in acute care hospitals in Liguria, Italy 123
Lopinavir/ritonavir exposure in treatment-naive HIV-infected children following twice or once daily administration 122
Piperacillin-Tazobactam monotherapy in high-risk febrile and neutropenic cancer patients 122
Occurrence, presentation and treatment of candidemia. 122
Lower sensitivity of serum (1,3)-β-D-glucan for the diagnosis of candidaemia due to Candida parapsilosis 122
Primary prevention of cryptococcal meningitis by fluconazole in HIV-infected patients. 121
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT). 121
Phase I study of simultaneous dose escalation and schedule acceleration of cyclophosphamide-doxorubicin-etoposide using granulocyte colony stimulating factor with or without antimicrobial prophylaxis in patients with small cell lung cancer 121
High-dose daptomycin in documented Staphylococcus aureus infections. 121
Piperacillin/tazobactam (TazocinTM) seems to be no longer responsible forfalse-positive results of the galactomannan assay 121
Reduction of fever and streptococcal bacteremia in granulocytopenic patients with cancer 120
Totale 13.836
Salva come PNG Salva come JPEG
Categoria #
all - tutte 149.211
article - articoli 138.831
book - libri 446
conference - conferenze 4.353
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 5.581
Totale 298.422
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010.967 0 0 0 0 0 1.557 2.325 1.052 1.398 2.502 1.549 584
2020/20214.117 243 452 382 303 269 394 146 393 367 464 320 384
2021/20226.259 177 308 375 832 222 665 319 1.486 329 590 178 778
2022/20236.263 658 363 78 650 996 1.250 21 479 1.060 80 551 77
2023/20242.833 140 426 73 323 275 513 146 163 204 69 167 334
2024/20253.712 156 703 250 557 1.287 759 0 0 0 0 0 0
Totale 51.957